TY - JOUR T1 - Efficacy of rituximab in refractory polymyositis. JF - The Journal of Rheumatology JO - J Rheumatol SP - 1369 LP - 1370 VL - 32 IS - 7 AU - Olivier Lambotte AU - Rami Kotb AU - Gwenola Maigne AU - François-Xavier Blanc AU - Cécile Goujard AU - Jean François Delfraissy Y1 - 2005/07/01 UR - http://www.jrheum.org/content/32/7/1369.abstract N2 - We describe the effectiveness of rituximab, an anti-B lymphocyte monoclonal antibody, in a case of refractory polymyositis with interstitial pulmonary disease and anti-Jo-1 autoantibody (antisynthetase syndrome). Rituximab was well tolerated, and its efficacy in inflammatory myositis should be evaluated. ER -